PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of wtpaEurope PMCEurope PMC Funders GroupSubmit a Manuscript
 
Lancet. Author manuscript; available in PMC 2010 August 9.
Published in final edited form as:
Lancet. 1993 January 23; 341(8839): 197–200.
PMCID: PMC2917763
EMSID: UKMS31606

Cysticercosis as a major cause of epilepsy in Peru

H. H. Garcia, R. Gilman, M. Martinez, V. C. W. Tsang, J. B. Pilcher, G. Herrera, F. Diaz, M. Alvarado, E. Miranda, and the Cysticercosis Working Group in Peru (CWG)

Abstract

In countries where cysticercosis is endemic, the proportion of epilepsy due to cysticercosis is not well documented. To investigate the association between cysticercosis and epilepsy, we used the enzyme-linked immunoelectrotransfer blot (EITB) assay to detect serum antibodies to Taenia solium in 498 consecutive outpatients at a neurology clinic in Lima, Peru. Every patient was classified as epileptic (n = 189) or non-epileptic (n = 309) after neurological, and where possible electroencephalographic, examination. A substantially higher proportion of epileptic than non-epileptic patients was seropositive in the EITB (22 [12%] vs 8 [3%], p < 0·00l). 19% of epileptic patients born outside Lima, 20% of those with late-onset epilepsy, and 29% of patients with both these characteristics were seropositive. Thus, in Peru, cysticercosis is an important aetiological factor for epilepsy.

Introduction

Neurocysticercosis is common in rural areas of developing countries where free-ranging pigs are raised.1,2 Clinically, the disorder can include many neurological symptoms, but epilepsy is the most common.2-5 Rural areas of developing countries have higher rates of epilepsy6,7 and of Taenia solium infection8 than do urban areas and developed countries. Neurocysticercosis resulting from the higher T solium infection rate may contribute to higher rates of epilepsy in these areas.9

The proportion of epilepsy cases associated with neurocysticercosis has not been well documented. Serological tests used to measure the prevalence of cysticercosis in epileptic populations were not highly sensitive or specific.10-11 However, the enzyme-linked immunoelectrotransfer blot (EITB) assay12,13 is 98% sensitive and 100% specific and can accurately diagnose T solium infection. We used the EITB assay to define the relation between epilepsy and cysticercosis in individuals attending a neurology outpatient clinic in Lima, Peru.

Patients and methods

The Instituto Nacional de Ciencias Neurológicas is the neurological reference centre for Peru and mainly serves the lower and middle class sectors of the population. New patients are randomly assigned to one of six neurology outpatient clinics for evaluation. All new patients attending one such clinic (consultorio no 2) between April, 1990, and June, 1991, were enrolled in this study after they had given informed consent. The study was approved by the ethical review boards of the Universidad Peruana Cayetano Heredia and the Johns Hopkins University.

A study nurse recorded information on birthplace, educational level, number of family members, and type of household (number of rooms, construction materials, source of water, and type of sewage facilities). Birthplace was classified as in Lima or outside Lima. This city (population 7 million) is the main urban centre of Peru, with about 35% of the country’s population. Nearly all pigs in the city are free of cysticercosis and are killed and processed in slaughterhouses with veterinary inspection.14 Patients were also asked whether they or close relatives had raised pigs, had passed flatworms, or had a history of seizures. Every patient was examined by a hospital neurologist and classified as epileptic or non-epileptic, and a venous blood sample was obtained. Clinical follow-up included electroencephalographic (EEG) examinations when possible. Computed tomography scans are rarely available for this population because of their high cost.

Serum samples were assayed by the EITB assay for antibodies specific to T solium.13 Seven lentil-lectin-purified T solium glycoprotein antigens were used in an immunoblot format to detect specific antibodies in serum. Antibody binding to these glycoproteins was visualised with the hydrogen peroxide/diaminobenzidine substrate, and a sample showing reactions to one or more glycoproteins was taken as positive. The assay was repeated when results were ambiguous. Tests were done at the Laboratory of Parasitology of the Universidad Peruana Cayetano Heredia and repeated at the Centers for Disease Control in Atlanta, USA, for quality control.

The chi-square and Fisher’s exact tests were used for the analysis of categorical variables and Student’s t test and the Mann-Whitney test for continuous variables, by means of SPSS statistical software (SPSS Inc, Chicago, USA). With either the result of the EITB test or the presence or absence of epilepsy as the outcome variable, we tested several logistic regression models to assess the individual contribution of each of the following variables: birthplace, education, history of raising pigs, history of passing flatworms, property status (owner, lenant, or lodger), presence of dirt floor or adobe or cane walls, number of rooms and number of inhabitants in house, source of water, and presence of household sewage connections. Significance was set at 0.05. Statistical significance was assessed by the likelihood ratio test in the logistic regression analysis with EGRET statistical software (Statistic and Epidemiology Research Corporation, Seattle, USA).

Results

Of the 506 patients examined, 8 (2%) refused to take part. 189 (38%) of die remaining 498 patients were classified as epileptic. Epileptic patients were younger than non-epileptic patients and higher proportions had passed flatworms or were seropositive for cysticercosis by the EITB assay. As expected, more epileptic than non-epileptic patients had abnormal EEGs (table I).

TABLE I
CHARACTERISTICS OF 498 PATIENTS

Table II compares patients who were positive and negative in the EITB; there were significant differences between these groups in the proportions born outside Lima, who had raised pigs, and who had passed flatworms. Male patients had a higher frequency of seropositivity than female patients and the proportion seropositive was higher among patients older than 20 years than in younger patients (27/357 [8%] vs 3/141 [2%], p = 0·037).

TABLE II
COMPARISON OF SEROPOSITIVE AND SERONEGATIVE PATIENTS

The age of seizure onset was recorded for 166 of the 189 epileptic patients. There were no significant differences between these patients and those with unknown age of seizure onset in age, birthplace, history of pig raising, history of passing flatworms, or proportion of abnormal EEGs. Among the patients with known age of epilepsy onset, the 20 seropositive patients were older at onset than were the 146 seronegative patients (mean 30·0 [SD 13·2] vs 22·8 [14·4] years, p < 0·01). The proportion seropositive was significantly greater among patients with late-onset (after age 20) epilepsy than in those with epilepsy of earlier onset (15/74 [20%] vs 5/92 [5%], p = 0·007, odds ratio 4·4). The highest proportion of seropositives was found among patients with late-onset epilepsy who had been born outside Lima (14/49 [29%] vs 6/117 [5%] of other patients, p < 0·001, odds ratio 7·4, table III).

TABLE III
ASSOCIATION OF BIRTHPLACE AND AGE OF ONSET OF EPILEPSY WITH SEROPREVALENCE TO T SOLIUM INFECTION AMONG EPILEPTIC PATIENTS

Of the 23 patients with unknown age at epilepsy onset, 14 (12 EITB negative, 2 EITB positive) were older than 20 years at the time of the study. If all 12 seronegative patients are taken as late onset and the 2 seropositive patients as early onset, the association between late-onset epilepsy and seropositivity remains significant (p = 0·041, odds ratio 2·9).

A family history of epilepsy was more common among epileptic than among non-epileptic patients (44/92 [48%] vs 112/324 [35%], p = 0·028). Patients with a family history of epilepsy were younger than those without such a history (mean 28·8 [14·4] vs 34·9 [17·0] years, p < 0·005) and a greater proportion had raised pigs (46/91 [51%] vs 119/324 [37%], p = 0·024). These groups did not differ as regards sex ratio, EITB results, flatworm passage, or the proportion with abnormal EEG findings.

Table IV gives unadjusted odds ratios for risk factors associated with epilepsy or with EITB seropositivity. By multiple logistic regression, the best-fit model for epilepsy as outcome variable included a positive EITB result (adjusted odds ratio 4·7) absence of drinking water in the house (2·3), and fewer than four rooms in the house (1·6); the likelihood ratio of the model statistic (4 df) was 52·71 (p < 0·001). The model that best fitted the data when the probability of a positive EITB result was the outcome variable included birthplace outside Lima (adjusted odds ratio 3·3) and a history of raising pigs (2·7); the likelihood ratio statistic of this model (3 df) was 456·57 (p < 0·001).

TABLE IV
RISK FACTORS ASSOCIATED WITH EPILEPSY OR WITH EITB SEROPOSITIVITY

A higher proportion of epileptic patients underwent EEG examinations than did non-epileptic patients (107/189 [57%] vs 131/309 [42%], p = 0·003). The 238 patients who had EEGs were significantly younger than those who did not, but they were similar as regards sex, birthplace, EITB results, and histories of pig raising and passing flatworms. Seropositive patients tended to have a higher frequency of abnormal EEG findings than did seronegative patients (table II). The proportion of seropositivity was similar for patients with focal EEG abnormalities (3/31 [10%]) and for those with generalised abnormalities (5/43 [12%]). 1 case reported as “abnormal” had no further information in the notes. Of the 8 EITB-positive patients classified as non-epileptic, 5 underwent EEG examinations; 4 were abnormal. 2 showed general paroxysmal activity, 1 had focal paroxysms, and the other had an abnormal basal rhythm. 7 EITB-positive patients had cerebral computed tomography scans; 6 were epileptic. 6 scans showed cysticercoid lesions, and the other was normal. However, this patient had an EEG with focal abnormalities. 6 EITB-negative patients also underwent computed tomography; 1 (showing a single calcification) was diagnosed as showing cysticercosis.

Discussion

12% of epileptic patients attending an outpatient clinic in Peru had serological evidence of T solium infection. 29% of patients with late-onset epilepsy who were born outside Lima were seropositive, compared with only 1–2% of control populations living in Lima.15 Our results accord with those of a Mexican study, in which 50% of patients with late-onset epilepsy were diagnosed as having cysticercosis on the basis of computed tomographic appearance.16

Know causes of epilepsy include cerebrovascular disease, neoplasia, trauma, alcohol use, birth injury, and central nervous system (CNS) infections.7,9 Both birth injury and parasitic CNS infections are more common in rural than in urban settings.7 Although cysticercosis is often cited as a major cause of epilepsy in countries where T solium is endemic,4,5,16,17 few accurate data are available. In one serological study,17 25% of a highly selected group of epilepsy patients were seropositive, but the test used was not highly sensitive or specific. Perhaps the best demonstration of the close relation between epilepsy and cysticercosis was in New Guinea; cysticercosis was introduced by imported pigs in 1972 and there was a substantial increase in the number of burns because this population commonly uses open fires, and burns occurred when individuals having seizures fell into fires. 18,19

In cysticercosis, the average time between the acquisition of infection and development of symptoms is about 7 years,5 but it can vary widely. Therefore, a proportion of seropositive patients in any population will be symptom-free. In cysticercosis-endemic communities, it is likely that most seropositive patients either do not have symptoms or do not seek medical attention.20,21 In addition, the number of seropositive individuals with subclinical abnormalities (ie, EEG changes) is unknown. In our “non-epileptic” group 4 of 5 seropositive patients tested had abnormal EEG results. Our study was hospital-based, however, and results may differ from those obtained in the community.

Ownership of a latrine, type of sewage facilities, and number of bedrooms were recorded but not included in the models because of the low significance. 94% of our patients lived in houses with toilets (80%) or latrines (14%).

The finding that the major risk factor for epilepsy was a positive EITB result confirms the strong connection between T solium infection and epilepsy in Peru. Factors protecting individuals against T solium infection were birth in Lima and no history of pig raising. Both variables incorporate many others, such as endemicity of disease, environmental contamination, slaughterhouse inspection of pork, and better sanitary conditions.

Further elucidation of the natural history of cysticercosis and the response to treatment of patients with cysticercosis-associated epilepsy is needed. Community-based studies on the linkage between epilepsy and cysticercosis are being conducted in Peru. Cysticercosis should be strongly suspccted in developing countries among patients with late-onset epilepsy, especially those from pig-raising areas.

Acknowledgments

This study was supported by grants from the International Development Research Council of Canada, Concejo Nacional de Ciencia y Tecnologia, Peru, Fundacion Hipolito Unanue, and the RG-ER Fund. H. G. is the recipient of a grant from the Comision del Quinto Centenario del Descubrimiento de America.

REFERENCES

1. Mahajan RC. Geographical distribution of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, Beltran F, editors. Cysticercosis: present state of Knowledge and perspectives. Academic Press; New York: 1982. pp. 39–46.
2. Del Brutto OH, Sotclo J. Ncurocysticercosis: an update. Rev Infect Dis. 1988;10:1075–87. [PubMed]
3. Nash TE, Neva FA. Recent advances in the diagnosis and treatment of cerebral cysticercosis. N Engl J Med. 1984;311:1492–96. [PubMed]
4. McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri: review of 127 cases. Arch Neurol. 1982;39:534–39. [PubMed]
5. Dixon HBF, Hargreaves WH. Cysticercosis (T solium): a further ten years clinical study, covering 284 cases. Q J Med. 1944;13:107–21.
6. Plascencia M, Shorvon SD, Paredes D, et al. Epileptic seizures in an Andean region of Ecuador: incidencc and prevalence and regional variation. Neuroepidemiology. (in press)
7. Shorvon SD, Hart YM, Sander JWAS, Van Andel F. The management of epilepsy in developing countries. Royal Society of Medicine Services; London: 1991.
8. Acha JP, Aguilar FJ. Studies of cysticercosis in Central America and Panama. Am J Trop Med Hyg. 1964;13:48–53. [PubMed]
9. Shorvon SD. Epidemiology, classification, natural history and genetics of epilepsy. Lancet. 1990;336:93–96. [PubMed]
10. Tellez-Giron E, Ramos MC, Dufour L, Alvarez P, Montante M. Detection of Cysticercus cellulosae in cerebrospinal fluid by dot enzyme-linked immunosorbent assay (DOT-ELISA) and standard ELISA) Am J Trop Med Hyg. 1987;37:169–73. [PubMed]
11. Diwan AM, Cocker-Vann P, Brown DB, et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cysticerd of T solium. Am J Trop Med Hyg. 1982;31:364–69. [PubMed]
12. Diaz JF, Verstegui M, Gilman R, et al. Immunodiagnosis of human cysticercosis T solum a field comparison of antibody-ELISA, antigen-ELISA, and EITB assays in Peru. Am J Trop Med Hyg. 1992;46:610–15. [PubMed]
13. Tsang VCW, Brand J, Boyer E. Enzyme-linked immunoelectrotransferancy blot assay and glycoprotein antigens for diagnosing human cysticercosis (T solium) J Infect Dis. 1989;159:50–59. [PubMed]
14. Gonzalez AE, Cama V, Gilman RH, et al. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg. 1990;43:194–99. [PubMed]
15. Garcia HH, Martinez M, Gilman RH, et al. Diagnosis of cysticercosis in endemic regions. Lancet. 1991;338:549–51. [PMC free article] [PubMed]
16. Medina M, Rosas E, Rubio F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 1990;150:325–27. [PubMed]
17. Chopra JS, Kaur U, Mahajan RC. Cysticerciasis and epilepsy: a clinical and serological study. Trans R Soc Trop Med Hyg. 1981;75:4–9. [PubMed]
18. Bending J, Catford J. Epidemic of burns in New Guinea due to cerebral cysticercosis. Lancet. 1983;1:922. [PubMed]
19. Gajdusek DC. Introduction of T solium in West New Guinea with a note on an epidemic of burns from cystercus epilepsy in the Ekari people of the Wissel Lakes area. PNG Med J. 1978;21:329. [PubMed]
20. Diaz F, Garcia HH, Gilman R, et al. Epidemiology of tacniasis and cysticercosis in a Peruvian village. Am J Epidemiol. 1992;135:875–82. [PMC free article] [PubMed]
21. Sarti E, Schantz PM, Plancartc A, et al. Enzyme-linked immunosorbent assay (ELISA) for the detection of antibody to cisticerci of T solium. Am J Trop Med Hyg. 1992;46:677–85. [PubMed]